Searched for
API MANUFACTURING FACILITY
US drug regulator classifies Aurobindo Pharma arm's Andhra facility as 'voluntary action indicated'Aurobindo Pharma Limited has announced that its subsidiary, Apitoria Pharma Pvt Ltd, received a VAI classification for its facility. The cl...
India gets down to the nuts and bolts to give the world a taste of shuddh, Swadeshi qualityIndia’s ambition to take Swadeshi products to global markets faces a critical test: quality. From ZED certification and mandatory product s...
These mid-caps have ‘strong buy’ and ‘buy’ recos and upside potential of over 25%, according to analystsMore than anything else, what is important in the stock market at this point of time is to avoid a hybrid model of thinking. What this basi...
Blue Jet Healthcare evaluating Rs 500 crore investment in Andhra Pradesh API manufacturing facilityBlue Jet Healthcare is evaluating the acquisition of 50 acres of land in Andhra Pradesh for an API manufacturing facility. The company plan...
Aurobindo Pharma arm gets 'Voluntary Action Indicated' classification for Telengana facility from USFDAFollowing an inspection from September 7 to September 15, 2026, the US FDA granted Apitoria Pharma, a subsidiary of Aurobindo Pharma, a Vol...
Pharma & healthcare funds top mutual fund return charts with over 19% gains. Should investors invest now or wait for a correction?Pharma and healthcare mutual funds have topped return charts in 2026 with over 19% gains. While strong sector growth supports the outlook, ...
These large-, mid- and small-cap stocks have upside potential of up to 31% in 1 year, according to analystsIn the last two years, the world has learnt that you can never quite predict what US President Trump will do next. Tomorrow, to pull attent...
These mid-caps have ‘strong buy’ & ‘buy’ recos and upside potential of up to 28%, according to analystsGlobal markets on Wednesday celebrated the outcome of the US mid-term election as well as a sharp drop in oil prices. Oil prices, which at ...
Short-term headwinds, yes; owning the ecosystem is better: 20 healthcare stocks with downside risk of 23% to upside potential of 41%The healthcare sector is under scrutiny. The issue is pricing: What medicines cost and on what hospitals and the rest of the health ecosyst...
Pharma company Gufic buys luxury duplex in Mumbai’s Juhu for over Rs 236 crGufic has made a significant real estate purchase with the acquisition of a luxury apartment in Mumbai. The duplex is located in the upscal...
These large-, mid- and small-cap stocks can give more than 20% return in 1 year, according to analystsHere’s one thing that is worth clarifying, because it is in the headlines. Large global technology companies have been announcing heavy spe...
These mid-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of over 25%, according to analystsWhen a market is as jittery as it is right now, poor numbers are treated harshly. A new-age company in the business of buying and selling u...
Piramal Pharma cutting China exposure to manage supply-chain resilience, says Nandini PiramalIn a strategic move to enhance risk management, Piramal Pharma has drastically cut its reliance on Chinese raw materials to under 10%. The ...
Forget short-term pressure; in the long term, the right business is what pays: 5 mid-cap stocks with an upside potential of up to 36%We have said this before, and we say it again: No one can predict when the market will bottom out. You can see the bottom only in hindsight...
These mid-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of over 25%, according to analystsThe last few weeks have made one thing clear. Oil prices, US bond yields, corporate earnings, and the state of the world – all point the sa...
5 stocks with consistent score improvement and upside potential of up to 29 % in 1 year, according to analystsLook at how the market treated the stock of a large FMCG stock – one the best wealth creators of the past – just because it mentioned the r...
These large- and mid-cap stocks can give more than 20% return in 1 year, according to analystsThe next few weeks are critical, and one should not be in a hurry to make market-related decisions. Better to be cautious – to wait and wat...
These mid-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of over 25%, according to analystsWhy should one be careful of the market at this juncture? One reason is that stocks are still not cheap. Even after all the nervousness of ...
Groww Q2 profit jumps; Hocco eyes big funding scoopGroww reported strong quarterly earnings in the July-September period. This and more in today’s ETtech Top 5.
Maharashtra to soon introduce digital system for milk tracking to curb adulteration: FDA chiefMaharashtra Food and Drug Administration plans to introduce a digital system to trace milk production. This initiative aims to reduce adult...